Wu VC et al. compared the ECG changes of patients treated with SGLT2 inhibitors in DM2 with those of patients who were not treated with these drugs and concluded that there was no difference between the two groups [155]. This evidence concerns the gene SLC5A2 and myotonic dystrophy type 2.